Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Venz

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Disease Models & Mechanisms|May 17, 2014
A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformationHenning Sievert, Nora Pällmann, Katharine K Miller, et al.
Cancers|November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-NaphthoquinonesSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
International Journal of Cancer|December 24, 2015
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancerSergey A Dyshlovoy, Ekaterina S Menchinskaya, Simone Venz, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
Annals of the Rheumatic Diseases|November 18, 2025
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesisSophie Wolfgramm, Sara Alehashemi, Martin Wendlandt, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Disease Models & Mechanisms|May 17, 2014
A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformationHenning Sievert, Nora Pällmann, Katharine K Miller, et al.
Cancers|November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-NaphthoquinonesSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
International Journal of Cancer|December 24, 2015
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancerSergey A Dyshlovoy, Ekaterina S Menchinskaya, Simone Venz, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
Annals of the Rheumatic Diseases|November 18, 2025
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesisSophie Wolfgramm, Sara Alehashemi, Martin Wendlandt, et al.
Pageof 5